Login
Home
Charts
Search
Watchlist
Products

Kanchi Karpooram Ltd

KANCHI·BSE
392.00+0.56%Tue, 22 Sept '26 15:29

Kanchi Karpooram Ltd

KANCHI
BSE
392.00
+0.56%
|Tue, 22 Sept '26 15:29
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
170Cr
Close
Close Price
392.00
Industry
Industry
Chemicals - Organic
PE
Price To Earnings
21.79
PS
Price To Sales
1.10
Revenue
Revenue
155Cr
Rev Gr TTM
Revenue Growth TTM
1.96%
PAT Gr TTM
PAT Growth TTM
-25.22%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
423131364736343639344042
Growth YoY
Revenue Growth YoY%
-41.5-40.7-36.3-15.712.015.88.50.4-16.7-4.519.216.4
Expenses
ExpensesCr
452828293735333336333935
Operating Profit
Operating ProfitCr
-3337101133116
OPM
OPM%
-7.78.810.119.620.91.81.98.27.82.33.115.3
Other Income
Other IncomeCr
011111111111
Interest Expense
Interest ExpenseCr
000000001000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
-433791133116
Tax
TaxCr
-111220011002
PAT
PATCr
-322570122015
Growth YoY
PAT Growth YoY%
-222.0-62.820.2550.4317.7-81.1-69.6-57.7-73.35.39.2113.2
NPM
NPM%
-7.86.56.914.515.11.11.96.14.81.21.811.2
EPS
EPS
-7.05.05.412.216.51.31.65.04.51.11.610.8
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
423131364736343639344042
Growth YoY
Revenue Growth YoY%
-41.5-40.7-36.3-15.712.015.88.50.4-16.7-4.519.216.4
Expenses
ExpensesCr
452828293735333336333935
Operating Profit
Operating ProfitCr
-3337101133116
OPM
OPM%
-7.78.810.119.620.91.81.98.27.82.33.115.3
Other Income
Other IncomeCr
011111111111
Interest Expense
Interest ExpenseCr
000000001000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
-433791133116
Tax
TaxCr
-111220011002
PAT
PATCr
-322570122015
Growth YoY
PAT Growth YoY%
-222.0-62.820.2550.4317.7-81.1-69.6-57.7-73.35.39.2113.2
NPM
NPM%
-7.86.56.914.515.11.11.96.14.81.21.811.2
EPS
EPS
-7.05.05.412.216.51.31.65.04.51.11.610.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
220146152149155
Growth
Revenue Growth%
-33.84.0-1.82.0
Expenses
ExpensesCr
200144133141143
Operating Profit
Operating ProfitCr
19118811
OPM
OPM%
8.81.011.95.47.4
Other Income
Other IncomeCr
12444
Interest Expense
Interest ExpenseCr
00011
Depreciation
DepreciationCr
33444
PBT
PBTCr
18118710
Tax
TaxCr
51523
PAT
PATCr
1301358
Growth
PAT Growth%
-101.76,048.6-60.9-25.2
NPM
NPM%
5.8-0.18.73.55.0
EPS
EPS
30.91.431.611.918.0
Financial YearMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
220146152149155
Growth
Revenue Growth%
-33.84.0-1.82.0
Expenses
ExpensesCr
200144133141143
Operating Profit
Operating ProfitCr
19118811
OPM
OPM%
8.81.011.95.47.4
Other Income
Other IncomeCr
12444
Interest Expense
Interest ExpenseCr
00011
Depreciation
DepreciationCr
33444
PBT
PBTCr
18118710
Tax
TaxCr
51523
PAT
PATCr
1301358
Growth
PAT Growth%
-101.76,048.6-60.9-25.2
NPM
NPM%
5.8-0.18.73.55.0
EPS
EPS
30.91.431.611.918.0

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
4444
Reserves
ReservesCr
193193206210
Current Liabilities
Current LiabilitiesCr
6767
Non Current Liabilities
Non Current LiabilitiesCr
1223
Total Liabilities
Total LiabilitiesCr
205205217224
Current Assets
Current AssetsCr
140134142117
Non Current Assets
Non Current AssetsCr
657175107
Total Assets
Total AssetsCr
205205217224
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
4444
Reserves
ReservesCr
193193206210
Current Liabilities
Current LiabilitiesCr
6767
Non Current Liabilities
Non Current LiabilitiesCr
1223
Total Liabilities
Total LiabilitiesCr
205205217224
Current Assets
Current AssetsCr
140134142117
Non Current Assets
Non Current AssetsCr
657175107
Total Assets
Total AssetsCr
205205217224

Cash Flow

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
16348-6
Investing Cash Flow
Investing Cash FlowCr
-34-35-77
Financing Cash Flow
Financing Cash FlowCr
-10-1-2
Net Cash Flow
Net Cash FlowCr
-19-10-1
Free Cash Flow
Free Cash FlowCr
-5250-10
CFO To PAT
CFO To PAT%
121.0-15,464.057.8-116.9
CFO To EBITDA
CFO To EBITDA%
79.72,364.542.4-75.9
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
16348-6
Investing Cash Flow
Investing Cash FlowCr
-34-35-77
Financing Cash Flow
Financing Cash FlowCr
-10-1-2
Net Cash Flow
Net Cash FlowCr
-19-10-1
Free Cash Flow
Free Cash FlowCr
-5250-10
CFO To PAT
CFO To PAT%
121.0-15,464.057.8-116.9
CFO To EBITDA
CFO To EBITDA%
79.72,364.542.4-75.9

Ratios

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
166154162136170
Price To Earnings
Price To Earnings
12.3257.211.826.421.8
Price To Sales
Price To Sales
0.81.11.10.91.1
Price To Book
Price To Book
0.80.80.80.60.8
EV To EBITDA
EV To EBITDA
7.472.66.215.713.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
15.610.821.614.014.0
OPM
OPM%
8.81.011.95.47.4
NPM
NPM%
5.8-0.18.73.55.0
ROCE
ROCE%
9.10.48.73.93.9
ROE
ROE%
6.5-0.16.32.42.4
ROA
ROA%
6.3-0.16.12.32.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
166154162136170
Price To Earnings
Price To Earnings
12.3257.211.826.421.8
Price To Sales
Price To Sales
0.81.11.10.91.1
Price To Book
Price To Book
0.80.80.80.60.8
EV To EBITDA
EV To EBITDA
7.472.66.215.713.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
15.610.821.614.014.0
OPM
OPM%
8.81.011.95.47.4
NPM
NPM%
5.8-0.18.73.55.0
ROCE
ROCE%
9.10.48.73.93.9
ROE
ROE%
6.5-0.16.32.42.4
ROA
ROA%
6.3-0.16.12.32.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Kanchi Karpooram Ltd is a family-run Indian manufacturer that has spent three decades turning imported pine-tree resin into synthetic camphor - the same white, aromatic block burned in temples and rubbed onto chests for colds across the country. Founded in 1992 by Mr. Suresh V Shah, a veteran with over 45 years in the camphor trade, the company has since used the cash flows of that single industrial product to buy city property and launch a trading arm in farm goods, all while staying debt-free. The recurring approach is simple: master one niche chemical process, then redeploy the surplus into unrelated but tangible assets - real estate and agricultural trading - that sit alongside the original factory. # Business segments Three engines at different stages - a manufacturing cash cow that makes camphor from imported gum, a property-development bet on Chennai land, and a small wholesale trading subsidiary in farm products - each built with the cash flows of the one before. ## 1. Synthetic camphor and allied products: the factory that funds everything else **A single plant in Kanchipuram cooks turpentine oil into camphor tablets and a suite of industrial by-products, selling mainly to other businesses while preparing to go direct to consumers.** - **Made from turpentine oil** - the process starts with gum turpentine oil, imported and chemically transformed through esterification, saponification and oxidation into synthetic camphor, which alone brought in roughly 79% of product sales in the latest year. - **One product, many lives** - camphor ends up in pharmaceutical creams and cough remedies, as a plasticiser that makes PVC flexible, as a fragrance in cosmetics, as a stabiliser in smokeless gunpowder, and in the high-volume religious tablet market where it is burned in rituals across India. - **By-products with their own demand** - the manufacturing process also yields dipentene (a paint-industry solvent and fragrance agent whose market has grown as citrus-based alternatives run short), isoborneol (a fragrance boosted by aromatherapy trends), and gum rosin and its derivatives, where management claims an "enviable share" and expects growing volumes. - **Competing on quality, not price** - the company faces low-cost Chinese imports and unorganised domestic players, so it leans on certified, compliant manufacturing that appeals to regulated buyers in pharmaceuticals and food-grade applications, where substandard imports cannot qualify. - **From factory gate to online cart** - having always sold business-to-business, the Board resolved in April 2026 to enter retail and digital sales, planning to brand and sell camphor tablets, cones, powders, gum rosin, and even religious goods like agarbattis and pooja kits through e-commerce platforms. ## 2. Real estate development: surplus cash turned into Chennai property **The company bought land and buildings in Chennai, then partnered with a builder to convert its Purasaiwalkam site into residential and commercial apartments on a profit-sharing basis.** - **Bought, not just built** - the real estate push began when the company purchased the Kilpauk office it had been leasing for Rs. 9.47 crore in November 2022, and earlier invested Rs. 43.18 crore in another Chennai property, all funded from internal accruals rather than debt. - **Own land reclassified as inventory** - during FY23, the company moved its investment property - land carried at roughly Rs. 39.5 crore and buildings at Rs. 3.70 crore - from the balance sheet into stock for development, formally marking its entry into the segment. - **Partnered, not solo** - in April 2023, it signed a joint venture with Prince Housing Chennai Private Limited to build on its Purasaiwalkam land, sharing profits without taking any equity stake in the partner entity or granting special rights. - **Shovels are moving** - by the latest year, all required government permits and approvals were in hand, and site preparation, water supply, and other pre-construction work were underway. ## 3. Agro products trading: a small subsidiary in farm goods **A wholly owned wholesale trader of spices, grains, dry fruits and other agricultural products, built through a tiny acquisition and still finding its feet.** - **Started with a 51% stake** - Kanchi Agro Product Private Limited was incorporated in April 2022 with Kanchi Karpooram paying Rs. 25.5 lakh for control, its objects covering everything from spices and oilseeds to raw cashew nuts, rice, herbs and pickles. - **Bought the rest for a rupee a share** - in September 2025, the company acquired the remaining 49% for Rs. 4.9 lakh, a nominal price reflecting the subsidiary's negative net worth, and turned it into a wholly owned unit. - **Small volumes, early stage** - the subsidiary generated turnover of Rs. 145 lakh in its first full year and Rs. 185 lakh in the next, modest figures that confirm it remains a peripheral activity alongside the camphor factory. # Group structure and partners **A tight, promoter-controlled setup with one wholly owned trading subsidiary, a profit-sharing real estate joint venture, and a related-party sales channel.** - The company has a single material subsidiary, Kanchi Agro Product Private Limited, now wholly owned and engaged in wholesale agro trading. - The real estate play is structured as a contractual joint venture with Prince Housing Chennai Private Limited - no equity held, no special rights, just a profit-sharing agreement over the Purasaiwalkam property. - A related party, M/s. Suresh Industries - where directors hold significant influence - buys camphor, gum rosin, turpentine and their derivatives from the company, creating a recurring inter-group sales channel. - Promoter shareholding stood at 47.01% after a reclassification in early 2022 moved a small block of shares to the public category, while aggregate foreign holding was 3.68% as of February 2023.

Documents — Kanchi Karpooram Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/d6xi11plhqv7ixfc5b972tdg.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/r51agv0kz7a1ftpdxhlnon2i.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/2u5guo552unf407fhb849pmh.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/k3sq9ro59qmcxl9yy9wn61pf.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/sm9enicd6tpr8gas9qed5pds.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/ocmfotecn8dxmcin79qjcdzs.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/43r4uzw1e9iyvp3l8yv9v5yc.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/933m57imyo9r4p4xi2l1ruhv.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/ien76gpqgrd5sqtznv33mg3m.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/sbva46iv7ssjwtigtxvb26mg.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/8jrr79232oqyf0nry5wc38jn.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/ndu7772mpncehwtn7epls1es.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/yfkr3fyye2eg1az0o2hs8hbg.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/aaz3fhh1os2uc4l3j0xsu9v8.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/i0g8737bq3v86c2jg9ri3jt7.pdf